Dr. Loggers is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office825 Eastlake Ave E
Seattle, WA 98109Phone+1 206-606-2018
- Is this information wrong?
- Dr. Elizabeth Loggers is an oncologist in Seattle, WA and is affiliated with multiple hospitals in the area, including University of Washington Medical Center and Seattle Cancer Care Alliance. She received her medical degree from University of Minnesota Medical School and has been in practice 14 years. She specializes in treatment of sarcomas and is expert in hospice and palliative care.
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2006 - 2009
- Massachusetts General HospitalResidency, Internal Medicine, 2003 - 2006
- University of Minnesota Medical SchoolClass of 2003
Certifications & Licensure
- ID State Medical License 2022 - 2024
- WA State Medical License 2009 - 2024
- MA State Medical License 2006 - 2010
- American Board of Internal Medicine Hospice and Palliative Medicine
- American Board of Internal Medicine Medical Oncology
- Enhancing Connections Program in Improving Family Adjustment in Patients With Incurable Cancer Start of enrollment: 2017 Apr 05
Publications & Presentations
- Bolus versus Continuous Intravenous Delivery of Doxorubicin in Soft Tissue Sarcomas: Post Hoc Analysis of a Prospective Randomized Trial (SARC021/TH CR-406).Lee D Cranmer, Yao Lu, Rachel S Heise, Karla V Ballman, Elizabeth T Loggers, Seth M Pollack, Michael J Wagner, Denise K Reinke, Patrick Schöffski, William D Tap> ;Clinical cancer research : an official journal of the American Association for Cancer Research. 2023 Jan 9
- Assessment of Oncology Advanced Practice Professional Willingness to Participate in Medical Aid in Dying.Jonathan Singer, Courtney Daum, Megan J Shen, Gabrielle Zecha, Louise Kaplan, Kathy Plakovic, Meagan Blazey, Molly Arnold, Barbara Silko, Kelsey Baker, Elizabeth T Log...> ;JAMA network open. 2022 Oct 3
- Demographics, Outcomes, and Risk Factors for Patients with Sarcoma and COVID-19: A CCC19-Registry Based Retrospective Cohort Study.Michael J Wagner, Cassandra Hennessy, Alicia Beeghly, Benjamin French, Dimpy P Shah, Sarah Croessmann, Diana Vilar-Compte, Erika Ruiz-Garcia, Matthew Ingham, Gary K Sc...> ;Cancers. 2022 Sep 5
- Join now to see all
- Low Achievement of End of Life Quality Measures in Large B-Cell Lymphoma Patients Who Progressed after CD19-Specific CAR-T Cell TherapyElizabeth Loggers, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Efforts Continue to Expand Immunotherapy Impact in SarcomaJanuary 12th, 2017
- Risk of Colon Cancer Recurrence in Relation to DiabetesSeptember 22nd, 2019
- Washington's Death with Dignity Act: Study Details SCCA's Plan to Honor Both Patients' Wishes and Voters' MandateFebruary 10th, 2016
- UW Medicine/University of Washington Medical CenterSeattle, Washington
- Fred Hutchinson Cancer CenterSeattle, Washington
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: